Drug Facts
Composition & Profile
Identifiers & Packaging
HOW SUPPLIED Sterile Erythromycin Ophthalmic Ointment USP, 5 mg/g as follows: 3.5 g (1/8 oz) tamper-evident tubes NDC 68788-8517-3 24 x 3.5 g (1/8 oz) Hospital-Pak (for hospital use only) NDC 0574- 4024 -39 Carton of fifty (50) Unit Dose 1 g tubes NDC 0574- 4024 -50 Store at controlled room temperature 15°-30°C (59°-86°F). Avoid excessive heat. Protect from freezing.; Package/Label Display Panel - Label Rx Only NDC 68788-8516-3 Erythromycin Ophthalmic Ointment USP NET WT 3.5 g (1/8 OZ) STERILE Relabeled By: Preferred Pharmaceuticals Inc. . Erythromycin Ophthalmic Ointment USP 05%
- HOW SUPPLIED Sterile Erythromycin Ophthalmic Ointment USP, 5 mg/g as follows: 3.5 g (1/8 oz) tamper-evident tubes NDC 68788-8517-3 24 x 3.5 g (1/8 oz) Hospital-Pak (for hospital use only) NDC 0574- 4024 -39 Carton of fifty (50) Unit Dose 1 g tubes NDC 0574- 4024 -50 Store at controlled room temperature 15°-30°C (59°-86°F). Avoid excessive heat. Protect from freezing.
- Package/Label Display Panel - Label Rx Only NDC 68788-8516-3 Erythromycin Ophthalmic Ointment USP NET WT 3.5 g (1/8 OZ) STERILE Relabeled By: Preferred Pharmaceuticals Inc. . Erythromycin Ophthalmic Ointment USP 05%
Overview
Erythromycin Ophthalmic Ointment belongs to the macrolide group of antibiotics. It is basic and readily forms a salt when combined with an acid. The base, as crystals or powder, is slightly soluble in water, moderately soluble in ether, and readily soluble in alcohol or chloroform. Erythromycin ((3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-dideoxy-3- C -methyl-3- 0 -methyl-α-L- ribo -hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D- xylo -hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione) is antibiotic produced from a strain of Streptomyces erythraeus . It has the following structural formula: Each gram contains Erythromycin USP 5 mg in a sterile ophthalmic base of mineral oil and white petrolatum. Structure Image
Indications & Usage
: For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For prophylaxis of ophthalmia neonatorum due to N. gonorrhoeae or C. trachomatis . The effectiveness of erythromycin in the prevention of ophthalmia caused by penicillinase-producing N. gonorrheae is not established. For infants born to mothers with clinically apparent gonorrhea, intravenous or intramuscular injections of aqueous crystalline penicillin G should be given; a single dose of 50,000 units for term infants or 20,000 units for infants of low birth weight. Topical prophylaxis alone is inadequate for these infants.
Dosage & Administration
: In the treatment of superficial ocular infections, a ribbon approximately 1 cm in length of Erythromycin Ophthalmic Ointment should be applied directly to the infected structure up to 6 times daily, depending on the severity of the infection. For prophylaxis of neonatal gonococcal or chlamydial conjunctivitis, a ribbon of ointment approximately 1 cm in length should be instilled into each lower conjunctival sac. The ointment should not be flushed from the eye following instillation. A new tube should be used for each infant.
Warnings & Precautions
No warnings available yet.
Contraindications
: This drug is contraindicated in patients with a history of hypersensitivity to erythromycin.
Adverse Reactions
The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions. To report SUSPECTED ADVERSE REACTIONS, contact Perrigo at 1-866-634-9120 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.